BlackRock »

Inozyme Pharma shares owned by BlackRock

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by BlackRock

Quarter filed Position value Share count Share price at filing
2023-09-30 $9.4M 2.2M 4.20
2023-06-30 $11M 1.9M 5.57
2023-03-31 $2.6M 451k 5.73
2022-12-31 $448k 426k 1.05
2022-06-30 $2.0M 431k 4.71
2021-06-30 $15M 900k 17.06
2021-03-31 $17M 862k 19.83
2020-12-31 $13M 631k 20.61
2020-09-30 $13M 501k 26.20